Healx Ltd.

https://www.healx.io

LinkedIn: https://www.linkedin.com/company/healx

Healx Limited is a technology company from Cambridge University focused on accelerating rare disease treatments by redesigning drug discovery. Healx integrates AI, deep pharmacology expertise, and patient engagement to intelligently match treatments to disease patients. Healx was selected in the global ‘Disrupt 100’ list 2017, covered in the Harvard Business Review, and awarded ‘Cambridge Graduate Business of the Year’ 2016 by Business Weekly and ‘Life Science Business of the Year’ 2015 by Cambridge University Entrepreneurs. The company has raised capital from Balderton Capital, Amadeus Capital Partners and Jonathan Milner. *

	Start	2014-01-01 established
	Industry	HealNet AI platform
	Industry 2	artificial intelligence (AI) / machine learning (ML)
	Person	Guilliams, Tim (Healx 201807 CEO + Co-Founder)
	Person 2	Milner, Jonathan (Abcam 201409 Deputy Chairman + largest shareholder before CEO + Co-founder)

	Region	Cambridge, Cambridgeshire
	Country	United Kingdom (GB)
	Street	66–68 Hills Road Charter House
	City	CB2 1LA Cambridge, Cambridgeshire
		Address record changed: 2024-01-05

Basic data	Employees	n. a.

		* Document for »About Section«: Healx Ltd.. (7/26/18). "Press Release: Healx Raises $10m as Investors Back AI to Find Rare Disease Treatments Faster". Cambridge.

		Record changed: 2022-07-25